Patient Registry of Blind Subjects With Sleep-related Problems
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Vanda Pharmaceuticals
- Study ID
- NCT01195558
- Status
- Recruiting
Conditions
- Sleep-wake Disorder in Blind Individuals
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Data collection on blindness and sleep problems — OTHERData related to degree of vision impairment and sleep problems is collected through a phone or web survey
Study Details
Non-24-hour sleep-wake disorder (Non-24) is a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness. This is a research protocol to develop a patient registry of subjects who may suffer from Non-24 and who are blind. Subjects participate in the study through a phone survey. This registry will be used to better understand, sleep related problems in blind individuals, including the investigation of a potential treatment, recruitment for future clinical studies, and to provide a forum for raising awareness about Non-24. The survey consists of questions regarding the degree of vision impairment and sleep problems that the subjects may be experiencing.
Key Dates
- Start date
- Apr 30, 2010
- Status verified
- Jun 2020
- Primary completion
- Apr 30, 2030
- Completion
- Apr 30, 2030
Study Design
- Enrollment
- 10,000 participants (estimated)
Arms
- Arm: Blind with sleep problemsBlind individuals with no light perception and with sleep-related problems who may suffer from Non-24
Primary Outcome Measure
Number of blind participants [ Time Frame: ongoing ]
Central Contacts
- Vanda Pharmaceuticals(202) 734-3400
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanda Pharmaceuticals | Washington D.C. | District of Columbia | 20037 | Vanda Pharmaceuticals 202-734-3400 |